Large-scale testing (Phase 3)Study completedNCT04505722
What this trial is testing
Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants
Who this might be right for
Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the Protocol
Janssen Vaccines & Prevention B.V. 44,325